The IMMP2L Knockout NCI-H1975 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal cell population derived from the NCI-H1975 human lung adenocarcinoma cell line, designed to disrupt the endogenous IMMP2L gene. This gene-edited model enables loss-of-function studies of IMMP2L within a heterogeneous cell population, avoiding clonal artifacts and better reflecting native biological variability. The polyclonal nature of this knockout product provides a robust platform for investigating mitochondrial biology in a cancer-relevant context.
The parental NCI-H1975 cell line was established from a female patient with non-small cell lung adenocarcinoma and serves as a well-characterized epithelial model for this malignancy. These adherent cells exhibit key features of lung adenocarcinoma, including specific driver mutations and signaling pathway dependencies, making them suitable for studies of tumor cell metabolism, apoptosis, and drug response. The knockout of IMMP2L in this background allows direct examination of mitochondrial protein processing in the context of lung adenocarcinoma pathophysiology.
IMMP2L encodes the catalytic subunit of the mitochondrial inner membrane peptidase (IMP) complex, which processes nuclear-encoded mitochondrial precursor proteins following import through TOMM/TIMM translocases. It forms a heterodimer with IMMP1L and cleaves N-terminal presequences from preproteins, enabling maturation of critical respiratory chain components such as cytochrome c oxidase and ATP synthase subunits. Upstream regulators including PPARGC1A, NRF1, TFAM, and HIF1A modulate IMMP2L expression in response to mitochondrial biogenesis and stress cues. Disruption of IMMP2L thus impairs mitochondrial proteostasis, respiratory chain assembly, and can activate quality control pathways like the mitochondrial unfolded protein response and mitophagy.
In the NCI-H1975 lung adenocarcinoma model, IMMP2L knockout allows direct assessment of how defective mitochondrial protein processing impacts cancer cell metabolism and viability. Mitochondrial dysfunction influences tumor progression through altered oxidative phosphorylation, ROS production, and apoptosis. By eliminating IMP complex activity, researchers can investigate the consequences on mitophagy, apoptosis, and metabolic reprogramming in a lung cancer context, potentially identifying therapeutic vulnerabilities. This model also offers insights into neurodevelopmental disorder mechanisms due to links between IMMP2L mutations and conditions such as Tourette syndrome and autism.
Key applications include studying mitochondrial protein import kinetics, respiratory chain assembly by blue native electrophoresis, and apoptosis induction via flow cytometry. Western blotting and RT-qPCR enable profiling of mitochondrial stress markers, while co-immunoprecipitation confirms IMP complex formation. ROS detection and mitochondrial respiration analysis (e.g., Seahorse) quantify functional outcomes. These polyclonal knockout cells are also amenable to drug screening for mitochondrial targets or proteomic identification of IMMP2L substrates. For further information, contact Ascent Research.
